Literature DB >> 2455529

Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta.

P J Chiu1, G Tetzloff, H S Ahn, E J Sybertz.   

Abstract

Vinpocetine is a highly specific inhibitor of calmodulin-dependent phosphodiesterase (CaM-PDE) with an IC50 of 19 microM and produces a significant accumulation of cyclic GMP but not cyclic AMP in rabbit aorta. In isolated rabbit aortic strips, vinpocetine (0.01 and 0.1 mM) inhibited the contraction and 45Ca uptake due to both phenylephrine (1 microM) and KCl (40 mM), whereas 8-Br-cyclic GMP (0.1-1mM) selectively impaired phenylephrine-induced responses. Furthermore, the KCl-stimulated 45Ca efflux in normal Ca2+ buffer, which reflects elevated cytosolic Ca2+, was greatly diminished by vinpocetine but not by 8-Br-cyclic GMP. However, phenylephrine-induced 45Ca efflux and contraction in Ca2+-free buffer, which reflect Ca2+ release from intracellular sites, were similarly inhibited by both vinpocetine and 8-Br-cyclic GMP. The results suggest that vinpocetine may effect vasodilatation through blockade of the slow channel and selective inhibition of CaM-PDE in the vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455529     DOI: 10.1093/ajh/1.3.262

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells.

Authors:  Kye-Im Jeon; Hirofumi Jono; Clint L Miller; Yujun Cai; Soyeon Lim; Xuan Liu; Pingjin Gao; Jun-Ichi Abe; Jian-Dong Li; Chen Yan
Journal:  FEBS J       Date:  2010-11-16       Impact factor: 5.542

Review 2.  An update on vinpocetine: New discoveries and clinical implications.

Authors:  Yi-Shuai Zhang; Jian-Dong Li; Chen Yan
Journal:  Eur J Pharmacol       Date:  2017-11-26       Impact factor: 4.432

3.  The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.

Authors:  T Zelles; L Franklin; I Koncz; B Lendvai; G Zsilla
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.

Authors:  Clint L Miller; Masayoshi Oikawa; Yujun Cai; Andrew P Wojtovich; David J Nagel; Xiangbin Xu; Haodong Xu; Vince Florio; Sergei D Rybalkin; Joseph A Beavo; Yiu-Fai Chen; Jian-Dong Li; Burns C Blaxall; Jun-ichi Abe; Chen Yan
Journal:  Circ Res       Date:  2009-09-24       Impact factor: 17.367

5.  Cyclic nucleotide phosphodiesterase 1 and vascular aging.

Authors:  Chen Yan
Journal:  Clin Sci (Lond)       Date:  2015-09-15       Impact factor: 6.124

6.  The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria.

Authors:  Gergely Svab; Judit Doczi; Akos A Gerencser; Attila Ambrus; Ferenc Gallyas; Balazs Sümegi; László Tretter
Journal:  Neurochem Res       Date:  2019-09-18       Impact factor: 3.996

Review 7.  Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.

Authors:  Matěj Malík; Pavel Tlustoš
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.